U.S. Markets closed

Should Stemline Therapeutics, Inc. (NASDAQ:STML) Be Your Next Stock Pick?

Simply Wall St

Stemline Therapeutics, Inc. (NASDAQ:STML) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of STML, it is a company with robust financial health as well as a excellent future outlook. In the following section, I expand a bit more on these key aspects. If you're interested in understanding beyond my broad commentary, take a look at the report on Stemline Therapeutics here.

Flawless balance sheet with high growth potential

STML is an attractive stock for growth-seeking investors, with an expected earnings growth of 74% in the upcoming year. The optimistic bottom-line growth is supported by a similarly outstanding revenue growth over the same time period, which indicates that earnings is driven by top-line activity rather than purely unsustainable cost-reduction initiatives. STML's strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. This indicates that STML has sufficient cash flows and proper cash management in place, which is a crucial insight into the health of the company. Investors should not worry about STML’s debt levels because the company has none! This means it is running its business only on equity capital funding, which is typically normal for a small-cap company. Therefore the company has plenty of headroom to grow, and the ability to raise debt should it need to in the future.

NasdaqCM:STML Past and Future Earnings, August 14th 2019

Next Steps:

For Stemline Therapeutics, I've put together three fundamental aspects you should further research:

  1. Historical Performance: What has STML's returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
  2. Valuation: What is STML worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether STML is currently mispriced by the market.
  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of STML? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.